Strong p16 immunohistochemical staining with block cytoplasmic and nuclear staining in >70% of the tumor cells (as defined by the College of American Pathologists [34]) was seen in 45 (6.8%) cases (Figure 5B, Table 2). Here, CDKN2A is linked to neoplasm.